
Strides Pharma Science Limited has informed the Exchange about press release dated 17-Mar-2022 titled Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange about press release dated 17-Mar-2022 titled Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science